Re: Pre-dosing with drug to screen patients for trials
The closest analogy to the design I was suggesting is the trial that Pfizer used for Maraviroc where the patients were screened by a tropism assay (from Monogram) and only those that responded went on to Maraviroc dosing, the non-responders were not included in the dosing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.